Highlights
AMEX: INO       Inovio Pharma
Last Price Today's Change   Day's Range   Trading Volume
4.24   +0.40 (10.42%)  4.12 - 4.70  24,626,600

Overview

 
Avg Volume (4 weeks):3,317,650
4 Weeks Range:2.95 - 4.70
4 Weeks Price Volatility (%):
73.71%
52 Weeks Range:1.915 - 5.11
52 Weeks Price Volatility (%):
72.77%
Average Price Target: 0.70
Price Target Upside/Downside: -3.54

Headlines



No recent Headlines for this stock.


Business Background

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

  Be the first to like this.
 
selamba so good counter
05/08/2013 8:11 PM


 

1843  6298  540  225 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VXX 14.24+0.75 
 EEM 44.60-0.36 
 SPY 328.77-2.95 
 INTC 68.47+5.15 
 AMD 50.35-1.36 
 CHK 0.558-0.015 
 F 9.00-0.14 
 NIO 4.66-0.26 
 AVP 5.60-0.05 
 GE 11.71-0.06 
Partners & Brokers